Detection of bone marrow micrometastasis and microcirculating disease in rhabdomyosarcoma by a real-time RT-PCR assay

Journal of Cancer Research and Clinical Oncology

Volumn 132, Issue 6, 2006, Pages 356-362

  Gallego, Soledad ^a   Llort, Anna ^a   Roma, Josep ^a   Sabado, Constantino ^a   Gros, Luis ^a   Sanchez De Toledo, Josep ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Circulating tumor cells; Micrometastatic disease; Minimal residual disease; Real time PCR; Rhabdomyosarcoma

Indexed keywords

CARBOPLATIN; CHOLINERGIC RECEPTOR; CYCLOPHOSPHAMIDE; DACTINOMYCIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; MESSENGER RNA; MYOD1 PROTEIN; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3; VINCRISTINE;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; BONE MARROW; BONE MARROW METASTASIS; CANCER RELAPSE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT PLANNING;

ADOLESCENT; BONE MARROW NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HUMANS; INFANT; MALE; MYOD PROTEIN; NEOPLASM CIRCULATING CELLS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; NEOPLASTIC CELLS, CIRCULATING; ONCOGENE PROTEINS, FUSION; RECEPTORS, NICOTINIC; RECURRENCE; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA, ALVEOLAR; RHABDOMYOSARCOMA, EMBRYONAL; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 33645124782     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-006-0083-y     Document Type: Article

References (19)

1. Athale U, Shurtleff S, Jenkins J, Poquette C, Tan M, Downing J, Pappo A (2001) Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor. J Pediatr Hematol Oncol 23:99-104
2. Avigad S, Cohen IJ, Zilberstein J, Liberzon E, Goshen Y, Ash S, Meller I, Kollender Y, Issakov J, Zaizov R, Yaniv I (2004) The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors. Cancer 100:1053-1058
3. Barr FG, Gallili N, Holich J, Biegel JA, Rovera G, Emanuel BS (1993) Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcomas. Nat Genet 3:113-117
4. Bridge JA, Liu J, Weibolt V, Suijkerbuijk R, Wenger G, Zhang J, Wan X, Baker KS, Sorensen P, Barr FG (2000) Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization: an Intergroup Rhabdomyosarcoma Study. Genes Chromosomes Cancer 27:337-344
5. Burchill SA, Lewis IJ, Abrams KR, Riley R, Imeson J, Pearson ADJ, Pinkerton R, Selby P (2001) Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for Tyrosine Hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year. J Clin Oncol 19:1795-1801
6. Davis RJ, D'Cruz CM, Lowell MA, Biegel JA, Barr FG (1994) Fusion of PAX7 to the FKHR by the variant t(1;13) (p36;q14) translocation in alveolar rhabdomyosarcomas. Cancer Res 54:2869-2872
7. Frascella E, Rosolen A (1998) Detection of the MyoD1 transcript in rhabdomyosarcoma cell lines and tumor samples by reverse transcription polymerase chain reaction. Am J Pathol 152:577-583
8. Gattenloehner S, Vincent A, Leuschner I, Tzartos S, Muller-Hermelink H, Kirchner T, Marx A (1998) The fetal form of acetylcholine receptor distinguishes rhabdomyosarcomas from other childhood tumors. Am J Pathol 152:437-444
9. Gattenloehner S, Dockhorn-Dworniczak, Leuschner I, Vincent A, Müller-Hermelink H, Marx A (1999) A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: Implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas. J Mol Diagn 1:23-31
10. Kelly KM, Womer RB, Barr FG (1996) Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase-polymerase chain reaction method. Cancer 78:1320-1327
11. T method. Methods 25:402-408
12. Loh WE Jr, Scrable HJ, Livanos E, Arboleda MJ, Cavenee WK, Oshimura M, Weissman BE (1992) Human chromosome 11 contains two different growth suppressor genes for embryonal rhabdomyosarcoma. Proc Natl Acad Sci USA 89:1755-1759
13. Maurer HM, Beltangady M, Gehan EA, Crist W, Hammond D, Hays DM, Heyn R, Lawrence W, Newton W, Ortega J (1988) The Intergroup Rhabdomyosarcoma Study I. A final report. Cancer 61:209-220
14. Michelagnoli MP, Burchill SA, Cullinane C, Selby PJ, Lewis IJ (2003) Myogenin: a more specific target for RT-PCR detection of rhabdomyosarcoma than MyoD1. Med Pediatr Oncol 40:1-8
15. Mocellin S, Rossi CR, Pilati P, Nitti D, Marincola FM (2003) Quantitative real-time PCR: a powerful ally in cancer research. Trends Mol Med 9:189-195
16. Newton WA Jr, Gehan EA, Webber BL, Marsden HB, van Unnik AJ, Hamoudi AB, Tsokos MG, Shimada H, Harms D, Schmidt D (1995) Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification - an Intergroup Rhabdomyosarcoma Study. Cancer 76:1073-1085
17. Tokunaga E, Maehara Y, Oki E, Koga T, Kakeji Y, Sugimachi K (2000) Application of quantitative RT-PCR using "TaqMan" technology to evaluate the expression of CK 18 mRNA in various cell lines. J Exp Clin Cancer Res 19:375-381
18. Thomson B, Hawkins D, Felgenhauer J, Radich (1999) RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VAC-IME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma. Bone Marrow Transplant 24:527-533
19. Weigelt B, Bosma AJ, Hart AA, Rodenhuis S, van't Veer LJ (2003) Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients. Br J Cancer 88:1091-1094